Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies

Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies

US Patent 9938346 · Granted Apr 10, 2018

Estimated economic value: $1,600,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific agonistic antibodies to activin a receptor like type 1 (ALK1)2025
Inhibitors of (αv)(β6) integrin2025
Methods for treating pancreatic cancer using combination therapies2025
Integrated biogas treatment and carbon dioxide based disinfection for water trea2025
Antagonists of human integrin α4β72025
Inhibitors of (α-v)(β-6) integrin2024
Non-invasive system and method for product formulation assessment based on produ2024
Integrated biogas treatment and carbon dioxide based disinfection for water trea2024
Anti-PSMA antibodies and uses thereof2024
Recombinant human sialidases, sialidase fusion proteins, and methods of using th2024
Biofeedback for awareness and modulation of mental state using a non-invasive br2024
Combination therapy for cancer treatment2023